Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Study to Investigate the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents

NCT02776215 is registered in ClinicalTrials.gov with Vanda Pharmaceuticals as lead sponsor.

NCT NCT02776215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02776215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Study to Investigate the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
Lead sponsor
Vanda Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
October 4, 2016
Completion date
December 20, 2017
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, circadian rhythm sleep disorders, non-24 hour sleep-wake disorder, smith-magenis syndrome